CNN: FDA authorizes Pfizer/BioNTech Covid-19 vaccine boosters for 16- and 17-year-olds
The US Food and Drug Administration on Thursday authorized the Pfizer/BioNTech Covid-19 vaccine for use as a booster in people ages 16 and 17. It’s the first Covid-19 vaccine booster authorized for this age group in the United States.
CNN writes: “The Pfizer vaccine is authorized for use in children as young as 5, but previously, only adults were eligible to receive booster doses.”
